Is airduo for wheezing?

Is AirDuo used for wheezing?

AirDuo contains fluticasone and salmeterol. It combines a corticosteroid and a long-acting beta-agonist. The drug reduces inflammation in the airways and relaxes muscles around them. AirDuo treats asthma in patients 12 and older. Wheezing is a symptom of narrowed airways. The medication helps control that symptom as part of broader asthma management.

How does AirDuo work against wheezing?

Fluticasone reduces swelling and mucus in the airways. Salmeterol keeps bronchodilation sustained over 12 hours. The pair addresses both inflammation and constriction that causes the audible whistling during breathing. AirDuo covers daily control rather than relief of acute episodes.

What happens if I use AirDuo for sudden wheezing?

AirDuo does not replace a rescue inhaler. Patients still need a short-acting beta-agonist such as albuterol for sudden symptoms. Using the combination product alone for rapid relief can leave gaps in treatment. Regimens require separate prescriptions for controller and rescue therapy.

How long does AirDuo take to start working?

Salmeterol reaches peak effect in 30 to 60 minutes. Full therapeutic benefits across both components build over days or weeks. Daily consistent use is required for steady control of symptoms like wheezing. Sudden changes in use or self-adjustment can risk symptom return.

What side effects are patients asking about?

Patients commonly report upper respiratory infections, headache, and voice changes. Hoarseness occurs when the fluticasone component reaches the voice box. Rinsing the mouth after each use reduces local effects. Rare risks include pneumonia in COPD patients, but AirDuo is not indicated for COPD.

Who makes AirDuo?

Teva Pharmaceuticals produces AirDuo. The company filed the original 505(b)(2) application through its subsidiary. The drug is available in three strengths: 55/14, 113/14, and 232/14 micrograms. Strength selection depends on prior asthma severity.

When does the AirDuo patent expire?

The Haulotte patent family expires in 2025. Haulotte held the co-formulation technique for dry-powder inhalers. Remaining exclusivity periods may cover device-specific patents or regulatory data protection. DrugPatentWatch.com tracks these dates and updates them regularly.

Can biosimilars or generics enter before patent expiry?

No generic versions trade under the combination of fluticasone/salmeterol for the AirDuo inhaler. Generics of the active ingredients exist separately, but device compatibility and bioequivalence studies delay entry.